Literature DB >> 15985463

Mutational analysis of action of mitochondrial fusion factor mitofusin-2.

Shinji Honda1, Takeshi Aihara, Masayasu Hontani, Katsuhiko Okubo, Shigehisa Hirose.   

Abstract

Mitofusin-2 (Mfn2) is an essential component of mitochondrial fusion machinery, but its molecular mechanism of action is not clear. We found that a Mfn2 deletion mutant lacking two transmembrane spans (Mfn(DeltaTM)) acts as a dominant-negative mutant and blocks mitochondrial fusion. Furthermore, detailed analysis of various mutants of Mfn(DeltaTM) revealed that GTPase activity and four regions highly conserved from nematodes to mammals are necessary for the dominant-negative effect. Immunoprecipitation studies of the N- and C-terminal cytosolic tails of Mfn2 showed that in addition to the coiled-coil domains previously identified, a highly conserved domain in the most N-terminal region and GTPase activity are necessary for the interaction between the N- and C-terminal tails, which is in turn required for the dominant-negative effect. In addition, we found unexpectedly that overexpression of the deletion mutant composed of one short region each in the N- and C-terminal tails of Mfn2 resulted in loss of mitochondrial membrane potential, suggesting that Mfn2 might also be connected to maintenance of mitochondrial membrane potential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985463     DOI: 10.1242/jcs.02449

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  20 in total

1.  Regulation of gene expression and mitochondrial dynamics by SMAD.

Authors:  Nirav Shah; Nam Y Lee
Journal:  Mol Cell Oncol       Date:  2016-06-30

2.  MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology.

Authors:  Nobuhiro Nakamura; Yasuo Kimura; Masaki Tokuda; Shinji Honda; Shigehisa Hirose
Journal:  EMBO Rep       Date:  2006-08-25       Impact factor: 8.807

3.  The heptad repeat domain 1 of Mitofusin has membrane destabilization function in mitochondrial fusion.

Authors:  Frédéric Daste; Cécile Sauvanet; Andrej Bavdek; James Baye; Fabienne Pierre; Rémi Le Borgne; Claudine David; Manuel Rojo; Patrick Fuchs; David Tareste
Journal:  EMBO Rep       Date:  2018-04-16       Impact factor: 8.807

4.  A novel mitofusin 2 mutation causes canine fetal-onset neuroaxonal dystrophy.

Authors:  John C Fyfe; Rabá A Al-Tamimi; Junlong Liu; Alejandro A Schäffer; Richa Agarwala; Paula S Henthorn
Journal:  Neurogenetics       Date:  2011-06-04       Impact factor: 2.660

5.  MFN2 mutations cause severe phenotypes in most patients with CMT2A.

Authors:  S M E Feely; M Laura; C E Siskind; S Sottile; M Davis; V S Gibbons; M M Reilly; M E Shy
Journal:  Neurology       Date:  2011-04-20       Impact factor: 9.910

6.  New insights into mitochondrial fusion.

Authors:  Yan Zhang; David C Chan
Journal:  FEBS Lett       Date:  2007-02-20       Impact factor: 4.124

7.  Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats.

Authors:  Ke-Xin Gan; Chao Wang; Jin-Hu Chen; Chun-Jing Zhu; Guang-Yao Song
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

8.  Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane.

Authors:  Nobuhiro Nakamura; Shigehisa Hirose
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

9.  Charcot-marie-tooth disease: seventeen causative genes.

Authors:  Jung-Hwa Lee; Byung-Ok Choi
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

10.  Activation of Mitofusin2 by Smad2-RIN1 Complex during Mitochondrial Fusion.

Authors:  Sanjay Kumar; Christopher C Pan; Nirav Shah; Sarah E Wheeler; Kari R Hoyt; Nadine Hempel; Karthikeyan Mythreye; Nam Y Lee
Journal:  Mol Cell       Date:  2016-05-12       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.